Clinical Trials Browser

Phase 2 × Meningioma × Radiosurgery × Clear all

NCT04659811 2026-04-15

Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma

Phase 2 Active not recruiting

Meningioma